What’s Next; What Matters—Back2Care.

What if you could use existing, standard lab and EHR data to identify individuals and populations who would benefit most from expedited care? As your partner for clinical insights, you can quickly leverage EarlySign’s AI expertise to optimize routine care, prioritize high risk patients, and re-engage populations.

Delivering compelling clinical and economic value – with speed and deep expertise – health care organizations can benefit from these packaged AI-powered clinical data solutions:

Infectious Disease Bundle

Prepare for a potential surge in COVID-19 cases as well as moderate to severe flu related complications

Admissions Bundle

Maximize savings by clearly understanding which patients are at greatest risk for readmissions and HAC’s while avoiding the costliest episodes

Early Detection Bundle

Prioritize and target interventions for patients at high risk for high burden disease with cost effective clinical data solutions

A Shared Mission.

When disruptions occur that knock us down, we admire those who get back up, dust off, and get back to work. In doing so, we get back to basics and leverage our training, tools, commitment to quality and excellence. Now, it’s time to get Back2Care. This is not to say that our passion for helping patients get better has ever left—in fact it has never been more clearly on display—but now it’s urgent that we get high-priority patients back into the care workflow. While the continued resilience of health systems will be tested, we remain driven to work across the continuum to get Back2Care.